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Abstract  
Background:  Silent  cerebral  events  (SCE)  have  been  identified  on  magnetic  resonance 
imaging  (MRI)  in  asymptomatic  patients  after  atrial  fibrillation  (AF)  ablation.  Procedural 
determinants  influencing  the  risk  for  SCE  still  remain  unclear.                   
Objective: Comparing the risk for SCE depending on exchanges of catheters (ExCath) over a 
single  transseptal  sheath.                                            
Methods: 88 Patients undergoing pulmonary vein isolation (PVI) only ablation using either 
single-tip  or  balloon-based  technique  underwent  pre-  and  post-ablation  cerebral  MRI. 
Ablations  were  either  performed  with  double  transseptal  access  and  without  exchanging 
catheters over the transseptal sheaths (group 1: no ExCath) or after a single transseptal access 
and exchanges of therapeutic and diagnostic catheters (group 2: ExCath). Differences in regard 
to SCE rates were analyzed. Multivariate analysis was performed to identify factors related to 
the  risk  for  SCE.                                                 
Results: Included  patients  underwent  PVI  using  single  tip  irrigated  radiofrequency  in  41, 
endoscopic laser balloon in 27 and cryoballoon in 20 cases. Overall SCE were identified in 23 
(26%) patients. In group 1 (no ExCath; N=46) 6 patients (13%) and in group 2 (N=42) 17 patients  
(40%) had documented SCE (p=0.007). The applied ablation technology did not affect SCE rate.  
In multivariate analysis age (OR 1.1, p=0.03) and catheter exchanges over a single transseptal 
sheath  (OR  12.1,  p=0.007)  were  the  only  independent  predictors  of  a  higher  risk  for  SCE.
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Conclusions:  Exchanging  catheters  over  a  single  transseptal  access  to  perform left  atrial 
ablation is associated with a significantly higher incidence of SCE compared to an ablation 
technique  using  different  transseptal  accesses  for  therapeutic  and  diagnostic  catheters.  
Key Words: Silent cerebral lesions, atrial fibrillation ablation, magnetic resonance imaging      
Introduction
Cerebral infarction is a rare but devastating complication of ablation procedures to treat atrial 
fibrillation (AF). But symptomatic cerebral ischemia may only be the tip of the iceberg as 
recent studies have identified cerebral lesions in asymptomatic patients after pulmonary vein 
isolation  (PVI)  undergoing  post-ablation  brain  magnetic  resonance  imaging  (MRI)  [1-4]. 
Incidences of silent cerebral events (SCE) appear to depend on ablation technology [2-6] and 
may be as high as 41% [4]. The clinical relevance of these post-ablation SCE still remains 
unclear. Different predictors of SCE have been identified but so far different procedural steps 
of the ablation procedure have not been evaluated in detail in regard to their potential risk [3-
8].  Exchanges  of  catheters  over  a  single  transseptal  sheath  may involve  a  higher  risk for 
embolic events due to manipulation of the sheath introducing air or thrombi. The present study 
evaluates the risk for SCE comparing left atrial ablation techniques using a single transseptal 
access  and  exchanging  diagnostic  and  therapeutic  catheters  to  a  technique  using  two 
transseptal  accesses,  one  for  each  catheter.                                          
Methods
Patients were eligible if undergoing pulmonary vein isolation (PVI) alone for paroxysmal or 
short-lasting persistent AF (< 3 months sustained AF) using either single-tip radiofrequency 
ablation (RF) or balloon-based technologies (cryo-balloon or endoscopic assisted laser-balloon 
ablation) and if willing and able to undergo cerebral MRI. Patients were categorized as either 
having paroxysmal or persistent AF based on current guidelines. All patients underwent MRI 
scanning one day before and 1 to 4 days after PVI. Baseline and procedural patient data was 
collected including procedure duration (from puncture to sheaths out), total ablation duration, 
minimal and mean procedural activated clotting time (ACT), periprocedural anticoagulation 
management (continued oral anticoagulation, bridging using low-molecular weight heparin), 
echocardiographic  evaluation  (left  atrial  enlargement  was defined as  left  atrial  dimensions 
being out of normal values, left ventricular ejection fraction), intraprocedural cardioversion or 
occurrence  or  persistence  of  AF.                                          
All patients were off anticoagulation at the day of the procedure and were bridged using low-
molecular weight heparin (half body-weight adjusted dose at day of the procedure and full 
body-weight  adjusted  dose  afterwards  until  adequate  oral  anticoagulation  was  achieved). 
Warfarin medication or novel oral anticoagulants were administered on day 1 after the ablation 
procedure  if  access  site  was  clinically  blunt.                                          
All  patients  gave  informed  consent  and  procedures  were  performed  after  exclusion  of 
intracardiac  thrombus  using  transesophageal  imaging.  Procedures  were  performed  under 
conscious sedation using propofol and via transseptal  access to the left  atrium in standard 
technique.
In both groups ablations were started only after the ACT reached ≥ 300sec. Intraprocedurally, 
ACTs were controlled every 20 minutes for the course of the procedure. Minimum ACT was 
documented for each procedure. All transseptal sheaths were flushed continuously with a rate 
of 150ml/hr. In cases with exchanges of catheters over a single transseptal sheath blood was 
aspired after taking catheters out and high-volume flushed (999ml/hr) until the next catheter 
was introduced. Care was taken to avoid any introduction of air into the transseptal apparatus. 
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Ablation procedures were performed using 3 different technologies as previously described 
[7,9-11]. Patient  selection for each ablation technique was based on operators` preference.
A neurological  evaluation  by  board-certified  neurologists  was  performed the  day of  post-
ablation MRI. In all cases only PVI was performed and no additional left atrial ablations were 
performed.
1.  Irrigated  tip  radiofrequency  (irrRF)  ablation  was  performed  using  CARTO3 (Biosense 
Webster, Diamond Bar, USA) or NavX (St. Jude Medical, St. Paul, USA) electroanatomic 
mapping system. Either single transseptal access (with one transseptal sheath and exchange of 
diagnostic and ablation catheters over the sheath) or double transseptal access (two different 
transseptal sheaths for the diagnostic and the ablation catheter) was performed. The circular 
diagnostic PV mapping catheter was used to create a 3-dimensional shell of the left atrium and 
prior  computed  tomography  images  were  integrated  by  merging.  In  all  cases  a  steerable 
transseptal  sheath (AGILIS™, St. Jude Medical,  St.  Paul, USA) was used for the ablation 
catheter  and  isolation  of  the  ipsilateral  PVs  was  performed  en-block  in  a  point-by-point 
fashion. Ablation was performed using a maximum of 35Watts with a target temperature of 
43ºC  and  a  maximum  irrigation  rate  of  30ml/min.                            
2.  Ablation  using  the  HeartLight™  Endoscopic  Ablation  system  (EAS)  (CardioFocus, 
Marlborough, USA) was performed after either a single or a double transseptal access. A CMC 
was used to  confirm bidirectional  PV block (either  as an exchange with the laser  balloon 
system in  patients  with  single  transseptal  approach  or  via  the  second  transseptal  sheath). 
Endoscopically  assisted  laser-balloon  ablations  for  PVI  were  performed  as  previously 
described  [11-13].  Ablations  were  performed  with  the  30º-angle  Argon  laser  to  produce 
overlapping lesions encircling the PV. Each ablation was performed for 20 to 30 seconds using 
5.5 to 12Watt energy as estimated by the operator. After completion of encircling (visually 
guided) the 10-pole circular mapping catheter was used to identify residual PV-conduction or 
block. If residual conduction was seen, further ablations were performed in that segment of the 
PV. In case of a single transseptal approach PV-conduction was tested after singular encircling 
of each PV exchanging catheters. If residual conduction was found, the catheters had to be 
exchanged  at  least  twice  to  perform further  ablations  and  check  afterwards.            
3. The ArcticFront™ (Medtronic, Minneapolis, USA) cryo-balloon (CB) was used for PVI. A 
single or double transseptal  access  (12 F FlexCath™, Medtronic,  Minneapolis,  USA) was 
performed and either a CMC was used for pre- and post-ablation evaluation (as an exchange of 
catheters  or  over  two distinct  accesses)  or  the  Achieve™ (Medtronic,  Minneapolis,  USA) 
catheter  was used as a guide-wire for the CB catheter  and for diagnosis  of PV-block (no 
exchange of catheters). At each PV at least two freezes lasting 300 seconds were carried out.  
In case of  usage of  the Achieve™ online monitoring  of  PV conduction  was possible  and 
further CB applications were performed directly if persistent PV conduction was found. If a 
single transseptal approach using a conventional circular mapping catheter was carried out, PV 
conduction was tested after performing 2 CB applications in each PV and the catheters had 
been exchanged.  Further CB applications  were performed if  persistent PV conduction was 
found  after  exchanging  the  catheters  again.  No  additional  focal  touch  up  ablations  were 
performed.
Exchange of Catheters over a single transseptal sheath                                  
Group 1: No exchange of catheters (no ExCath) was defined as two transseptal accesses using 
two distinct transseptal sheaths for the CMC and the ablation device (two separate transseptal 
sheaths)  or  if  the  Achieve™  catheter  was  used  through  the  inner  lumen  of  the  CB.
Group 2: Exchange of  catheters  over a  single transseptal  sheath (ExCath)  was defined as 
exchanging  CMC  and  ablation  device  at  least  twice  (CMC  before  and  after  ablation).  
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In all patients the endpoint of PVI was confirmed as bidirectional PV block including entrance 
block (loss of PV potentials) and exit block (when pacing the PV from distal the isolation site).
Cerebral  Magnetic  Resonance  Imaging  (MRI)                               
MRI scans were independently evaluated by two board-certified radiologists experienced in 
the  diagnosis  of  brain  MRI  scans  blinded  for  the  ablation  technology  used.           
Brain  MRI  was  1  to  3  days  after  ablation  and  during  follow-up  using  a  1.5-T  scanner 
(Magnetom  Avanto,  Siemens,  Erlangen,  Germany).  The  imaging  protocol  for  all  images 
consisted of a transaxial T2-weighted, fluid-attenuated inversion recovery (FLAIR) sequence 
(TI  2500ms,  TR  8500ms,  TE  112ms,  slice  thickness  5.0mm,  in-plane  resolution 
1.6x0.9x5.0mm3,  flip  angle 150º)  and a transaxial  diffusion-weighted echo-planar  imaging 
(DWI) sequence (TR 3300ms, TE 99ms, in-plane resolution 1.9x1.3x5.0mm3). For each DWI 
sequence, the apparent diffusion coefficient (ADC) map was obtained. Additionally, a sagital 
T1-weighted spin-echo sequence (TR 400ms, TE 13ms, in plane resolution 1.2x0.9x5.0mm3, 
flip angle 70º) was acquired for assessing brain anatomy and for ruling out haemorrhaging 
conversion  of  the  SCEs.                                                 
SCE was defined as a hyperintense lesion in DWI scans with a corresponding hypo-attenuated 
area  in  the  ADC  map.  The  FLAIR  sequence  was  not  used  to  define  SCE  (Figure  1). 
Occurrence, number and size of SCEs were documented for each individual patient. Proton 
density (PD)-scans were performed additionally in post-ablation follow up MRI to increase 
sensitivity  concerning  SCE.                                          
 
Figure 1: Post-ablation MRI with three distinct SCEs (white circle) not identified on FLAIR (A) but documented  
as  hyperintense  lesions  in  DWI (B)  and  corresponding  hypointense  lesion  in  ADC-map  (C)  defining  SCE.
Statistics
Statistical analyses were carried out with custom S-scripts for the statistical environment R 
2.10.1 for Mac OS X. Where not otherwise specified, data is presented as mean±standard error 
of the mean for normally distributed continuous data or median (interquartile range) for non-
normally  distributed  data  or  percentages.  Depending  from the  class  of  analyzed  data  and 
possible direction of causality, distributions were compared by means of multivariate logistic 
regression with forward selection, two sample t-test, Wilcoxons rank sum test or Pearson's 
Chi-squared  test  with  Yates'  continuity  correction.  For  multivariate  logistic  regression 
variables were selected that differed with p<0.1 in a-priori Chi-squared test or Wilcoxons test 
and  that  did  not  correlate  to  procedure,  respectively.  A  two-tailed  p  value  of  <0.05  was 
considered statistically significant in all  tests.                                             
Results
A total of 88 patients were included (41 patients treated with IrrRF, 27 with EAS and 20 with 
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CB) during the study period. 46 patients were ablated without exchange of catheters over a 
single transseptal sheath (group 1, no ExCath) and 42 with (group 2, ExCath) (baseline patient  
characteristics  see  Table  1).                                     
Table 1: Baseline,  procedural  and outcome data  comparing patients  without exchanges of 
catheters of a single transseptal sheath (group 1) to those with exchanges of catheter (group 2)
 
Post-ablation  cerebral  MRI                                                     
Brain MRI was performed at a median of 1 day after the procedure (1 to 4 days). 2 (2%) 
patients had old lacunar infarction and 35 (40%) had unspecific white matter lesions and glial 
scarring  identified  as  leucencephalopathy.                                      
No patient  had new-onset  neurological  symptoms indicative  of cerebral  ischemia  after  the 
procedure. 23 patients (26%) had documented SCE (8 (20%) patients treated with IrrRF, 10 
(37%)  with  EAS  and  5  (25%)  with  CB).  Overall  51  SCEs  were  identified  (2.2/patient; 
diameter in between 1 to 11mm), 41 (80%) were 3mm or less in diameter, 9 (18%) in between 
4  to  10mm and  1  (2%) was  larger  than  10mm in  diameter  (see  Figure  1).             
Effect  of  ExCath                                                 
Baseline and procedural characteristics in relation to ExCath are displayed in table 2. In Group 
1 patients (no ExCath) irrRF was more common compared to EAS and CB. Mean ACT tended 
to be higher in group 1 patients but without statistical significance (p=0.05).               
Incidence of SCE was significantly higher in group 2 patients (40%, 17/42) compared to those 
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group 1 (13%, 6/46) (p=0.004) (Table 2). Also, number per patient (2.2±0.63 versus 2.7±0.14, 
p=0.005)  and mean diameter  of  SCE (4±2mm vs.  5±04mm, p=0.45) differed significantly 
(Table  2).                                     
Table 2: Univariate comparison of baseline and procedural characteristics between the group 
of  patients  without  to  those  with  SCE                                    
 
Baseline  and  procedural  characteristics  comparing  patients  with  and  without  SCE  
Comparative analysis of baseline characteristics is shown in Table 1. No patient had detected 
noticeable  abnormalities  on  neurological  evaluation.                                  
Patients  with  SCE compared  to  those  without  were  significantly  older  (69±8  vs.  59±12, 
p=0.04) and significantly more often ExCath was performed (40% versus 74%, p=0.007).    
No difference in any other tested variable was identified comparing patients with and without 
SCE  (Table  2).                                                  
Comparison  in  between  ablation  technologies                                  
Comparing incidence of SCE and number of SCE/pt in between different ablation technologies 
did not reveal significant differences: The incidence of SCE was 20% in IrrRF (8 out of 41), 
30% in CB (6 out of 20) and 37% in EAS (10/27) patients (Figure 2).
Multivariate  analysis  of  risk  of  SCE                                             
In the multivariate analysis (Table 3) only age (p=0.03, OR 1.07) and ExCath (p=0.006, OR 
12.93) were independent significant predictors of increased risk for post-ablation SCL (Table 
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3). ExCath was associated with a 3.1-times increased relative risk for SCL. In multivariate 
analysis mode of ablation (irrRF, EAS, CB) did not affect SCE incidence.  
Figure 2:  SCE rates and SCE/pat in the different ablation groups
Table 3: Risk for SCE assessed by multiple logistic regression
Discussion
The presented data indicates that exchanging catheters over a single transseptal sheath during 
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left atrial ablations significantly influence the risk for acute SCE identified on post-ablation 
MRI. In addition, age was also associated (but not as strong) with an increased risk for SCE. 
Exchanges  of  catheters  and  risk  for  SCE                                     
We identified a significantly higher incidence of SCE in patients with catheter exchanges over 
the  transseptal  sheath  of  40% compared  to  13% in  the  group of  patients  ablated  without 
catheter exchanges. ExCath over a single transseptal sheath in our analysis was the strongest 
predictor for SCE associated with a 3.1-imes increased risk. Introducing and withdrawing a 
catheter over the transseptal sheath may lead to introduction of gas or thrombotic debris from 
within the transseptal  sheath or the catheter.  In addition,  ExCath over a single transseptal 
sheath may influence the patency of the sheath's valve and may then lead to introduction of 
small air bubbles. In patients undergoing either single-tip irrRF ablation or balloon-based PVI 
the technique may include either having two transseptal sheaths (one for the ablation device 
and one for the circular mapping catheter) or only a single transseptal sheath with the need for 
exchanging diagnostic and therapeutic catheters. Further studies are needed to identify e.g. the 
number  of  exchanges  that  may  be  detrimental  or  may  identify  differences  in  between 
transsseptal sheath designs or size. In our study catheter exchanges were performed at least 
twice in group 2 patients. ExCath over a single transseptal sheath should be avoided in order to 
reduce  the  incidence  of  SCE.                                            
Predictors,  so  far  identified  to  impact  SCE  rates,  are  intraprocedural  ACT  [3,5,6], 
intraprocedural cardioversion [3,6], echocontrast  on pre-ablation transesophageal echo [4,6] 
and ablation of sites with complex fractionated electrograms [6,14] as independent predictors 
of SCE. So far, data on all of these variables appears controversial [2-4,15] which may be 
related to the different MRI definitions (see below) or MRI technologies used. In our analysis 
using a high-sensitive MRI definition of SCE only older age and ExCath were independent 
predictors  of  SCE.                                         
Recently  a  study  on  phased  RF  ablation  using  the  PVAC catheters  indicated  that  subtle 
changes of the procedural steps lead to a dramatic reduction in FLAIR-positive silent cerebral 
lesions [16]. Further studies need to identify steps of left atrial ablation procedures most likely 
to  involve  embolism  and  generation  of  SCE.                                     
SCE  in  post-ablation  MRI                                 
SCE detected on cerebral MRI have been identified as a potential embolic complication of left 
atrial  ablation  procedures.  Incidence  of  detected  SCE  depends  upon  MRI  technique  and 
definition used. In our study we used a more sensitive ("new") definition of SCE characterized 
only by a hyperintensity on DWI-MRI and corresponding hypointense lesion on ADC-map. In 
contrast  to  other  (earlier)  studies  we have  not  included  the  FLAIR sequence,  which  may 
misclassify  some  DWI  hyperintense  lesions  as  negative  due  to  the  timeline  of  FLAIR 
becoming positive (usually over the first 48 hours or longer). This may lead to undertection of 
(mostly smaller) silent cerebral events in up to 2/3 of lesions [17]. Schmidt et al. [8] using the 
same definition as in our study found comparable silent cerebral event rates (for IrrRF 24%, 
for  Cryo  ablation  18% and  24% for  EAS  ablation).                                
In  summary,  using  a  more  sensitive  MRI definition  more  patients  with  SCE are  detected 
(higher incidences) and differences between technologies appear to be less pronounced.         
So  far,  the  exact  mechanism  of  SCE  generation  remains  unclear.  Recent  animal  studies 
indicate that silent cerebral lesions usually dissolved on MRI within 4 days after occurrence 
although glial scar formation was detected on histopathology. Lesions detected on DWI and 
FLAIR in this study appear to present small asymptomatic strokes. The incidence of SCE may 
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serve as a surrogate parameter for the embolic load of different left atrial ablation technologies 
and techniques. Whether different sizes of SCE represent different mechanisms (e.g. gaseous 
versus thrombotic embolism) and why and if lesions really remain asymptomatic using high 
precision  neuropsychological  testing  needs  to  be  further  elucidated.  So  far  no  study  has 
identified potential clinical sequel related to post-ablation SCE and their small number and 
size needs to be weighted against the high incidence and number of pre-existing white matter 
lesions  related  to  the  process  of  AF.                                            
Limitations
The  present  study  evaluates  SCE rates  related  to  intraprocedural  exchanges  of  left  atrial 
catheters  over  a  single  transseptal  sheath  using  a  sensitive  methodology.  Although  many 
baseline and procedural characteristics have been evaluated, other - so far unknown - factors 
may  also  play  a  role  or  may  only  become  visible  in  larger  patient  population.       
The number of exchanges of catheters over a single transseptal sheath and different sheath 
designs were not evaluated and further studies need to identify potential differences in regard 
to the sheath or technology used. It may be speculated that mismatches between catheter sizes 
and sheath diameter may also impact the risk for SCE.                          
Furthermore, the effect of continued anticoagulation or novel oral anticoagulant during left 
atrial  ablation  was  not  studied  in  the  present  evaluation.  Recent  data  indicates  relevant 
differences in SCE incidences in between patients ablated on continued oral anticoagulation 
versus other protocols (Deneke et al., 2013, presented at the Annual Scientific Congress of the 
American  Heart  Association,  Dallas).  This  was  not  tested  in  the  present  study  using  a 
prespecified  periprocedural  anticoagulation  protocol.                                 
Conclusions
Risk for SCE appears to be multifactorial: As a new but modifiable determinant we identified 
exchanges of catheters over a single transseptal sheath as a strong factor involving a higher 
risk for SCE. When using two different catheters for PVI diagnostics and ablation different 
accesses  (sheaths)  should  be  used  to  reduce  SCE  rates.                   
SCE rates may serve as an indicator for the embolic risk of a left atrial ablation technology or 
procedure. Procedural and technological changes to minimize the incidence of SCE should be 
attempted.
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